A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
This study has been terminated.
(Sponsor decided to discontinue study drug development)
Sponsor:
Agennix
Information provided by (Responsible Party):
Agennix
ClinicalTrials.gov Identifier:
NCT00313456
First received: April 10, 2006
Last updated: May 9, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | March 2009 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |